Hammersmith Hospital, formerly the Military Orthopaedic Hospital, and later the Special Surgical Hospital, is a major teaching hospital in White City, West London.

There are 349 beds in Hammersmith Hospital.

During the past decade, Hammersmith Hospital conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 56 clinical trials were completed, i.e. on average, 58.9% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 41 clinical trials were completed. i.e. 124.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hammersmith Hospital" #1 sponsor was "Imperial College London" with 26 trials, followed by "Actelion" with 7 trials sponsored, "Pfizer" with 7 trials sponsored, "University College, London" with 6 trials sponsored and "Celgene" with 6 trials sponsored. Other sponsors include 125 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hammersmith Hospital" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "Imperial College Healthcare NHS Trust" with 5 trials as a collaborator, "British Heart Foundation" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Celgene" with 3 trials as a collaborator. Other collaborators include 138 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "Hammersmith Hospital" are "Ovarian Cancer" (11 trials), "Fallopian Tube Cancer" (6 trials), "Acute Lymphoblastic Leukemia" (5 trials), "Acute Myeloid Leukemia" (5 trials) and "Coronary Artery Disease" (5 trials). Many other conditions were trialed in "Hammersmith Hospital" in a lesser frequency.

Most popular intervention types in "Hammersmith Hospital" are "Drug" (121 trials), "Procedure" (29 trials), "Other" (24 trials), "Biological" (16 trials) and "Device" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Gemcitabine" (6 trials), "Idelalisib" (5 trials), "carboplatin" (5 trials) and "Rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hammersmith Hospital" are 158 trials for "All" genders, 16 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 33 active trials in "Hammersmith Hospital". 1 are not yet recruiting, 16 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 98 completed trials in Hammersmith Hospital, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Hammersmith Hospital, 16 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 23 trials that are defined as “Not Applicable".

Hammersmith Hospital has several departments that took part in Clinical trials: "Charing Cross Hospital; Medical Oncology." - 11 trials, "The Liver Unit" - 2 trials, "Academic Vascular Surgery, Charing Cross Hospital" - 2 trials, "Peart-Rose Research Unit, Hammersmith Hospital, Imperial College NHS Trust" - 2 trials